The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Medical Hemostatic Agents Market Research Report 2025
Synopsis
Mechanical agents (also called passive substances) are generally thought to be the most effective for small amounts of bleeding and they create a barrier to stop blood flow and a surface that permits blood to clot more rapidly.
The global Medical Hemostatic Agents market was valued at US$ 3500.1 million in 2023 and is anticipated to reach US$ 5079.9 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.
North America is the largest consumption region, with a more than 40% market share. Then Europe is the second largest consumption region with the market share of about 30%. J&J, Baxter, BD, Gelita, Pfizer, B Braun are the leaders of the global Medical Hemostatic Agents market, and they hold more than 65% market share. Medical Hemostatic Agents is widely used in Hospital, Surgical Centers and other field. The most proportion of Medical Hemostatic Agents is Hospital, and the sales proportion is about 65%. The classification of Medical Hemostatic Agents includes Gelation Hemostats, Combination Hemostats and Others Type. The proportion of Combination Hemostats and Gelation Hemostats in 2019 is more than 50%.
This report aims to provide a comprehensive presentation of the global market for Medical Hemostatic Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Hemostatic Agents.
Report Scope
The Medical Hemostatic Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Medical Hemostatic Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Hemostatic Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
J&J
Baxter
BD
Gelita
Pfizer
B Braun
CSL Behring
Ferrosan Medical Devices
Advance Medical Solution
Medtronic
Z-Medica
Marine Polymer
Equimedical
CryoLife
Segment by Type
Gelation Hemostats
Combination Hemostats
Others
Segment by Application
Hospitals
Surgical Centers
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medical Hemostatic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medical Hemostatic Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Mechanical agents (also called passive substances) are generally thought to be the most effective for small amounts of bleeding and they create a barrier to stop blood flow and a surface that permits blood to clot more rapidly.
The global Medical Hemostatic Agents market was valued at US$ 3500.1 million in 2023 and is anticipated to reach US$ 5079.9 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.
North America is the largest consumption region, with a more than 40% market share. Then Europe is the second largest consumption region with the market share of about 30%. J&J, Baxter, BD, Gelita, Pfizer, B Braun are the leaders of the global Medical Hemostatic Agents market, and they hold more than 65% market share. Medical Hemostatic Agents is widely used in Hospital, Surgical Centers and other field. The most proportion of Medical Hemostatic Agents is Hospital, and the sales proportion is about 65%. The classification of Medical Hemostatic Agents includes Gelation Hemostats, Combination Hemostats and Others Type. The proportion of Combination Hemostats and Gelation Hemostats in 2019 is more than 50%.
This report aims to provide a comprehensive presentation of the global market for Medical Hemostatic Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Hemostatic Agents.
Report Scope
The Medical Hemostatic Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Medical Hemostatic Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Hemostatic Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
J&J
Baxter
BD
Gelita
Pfizer
B Braun
CSL Behring
Ferrosan Medical Devices
Advance Medical Solution
Medtronic
Z-Medica
Marine Polymer
Equimedical
CryoLife
Segment by Type
Gelation Hemostats
Combination Hemostats
Others
Segment by Application
Hospitals
Surgical Centers
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medical Hemostatic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medical Hemostatic Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Medical Hemostatic Agents Market Overview
1.1 Product Overview and Scope of Medical Hemostatic Agents
1.2 Medical Hemostatic Agents Segment by Type
1.2.1 Global Medical Hemostatic Agents Market Value Comparison by Type (2024-2030)
1.2.2 Gelation Hemostats
1.2.3 Combination Hemostats
1.2.4 Others
1.3 Medical Hemostatic Agents Segment by Application
1.3.1 Global Medical Hemostatic Agents Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Surgical Centers
1.3.4 Others
1.4 Global Medical Hemostatic Agents Market Size Estimates and Forecasts
1.4.1 Global Medical Hemostatic Agents Revenue 2019-2030
1.4.2 Global Medical Hemostatic Agents Sales 2019-2030
1.4.3 Global Medical Hemostatic Agents Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Medical Hemostatic Agents Market Competition by Manufacturers
2.1 Global Medical Hemostatic Agents Sales Market Share by Manufacturers (2019-2024)
2.2 Global Medical Hemostatic Agents Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Medical Hemostatic Agents Average Price by Manufacturers (2019-2024)
2.4 Global Medical Hemostatic Agents Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Medical Hemostatic Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Hemostatic Agents, Product Type & Application
2.7 Medical Hemostatic Agents Market Competitive Situation and Trends
2.7.1 Medical Hemostatic Agents Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medical Hemostatic Agents Players Market Share by Revenue
2.7.3 Global Medical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medical Hemostatic Agents Retrospective Market Scenario by Region
3.1 Global Medical Hemostatic Agents Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Medical Hemostatic Agents Global Medical Hemostatic Agents Sales by Region: 2019-2030
3.2.1 Global Medical Hemostatic Agents Sales by Region: 2019-2024
3.2.2 Global Medical Hemostatic Agents Sales by Region: 2025-2030
3.3 Global Medical Hemostatic Agents Global Medical Hemostatic Agents Revenue by Region: 2019-2030
3.3.1 Global Medical Hemostatic Agents Revenue by Region: 2019-2024
3.3.2 Global Medical Hemostatic Agents Revenue by Region: 2025-2030
3.4 North America Medical Hemostatic Agents Market Facts & Figures by Country
3.4.1 North America Medical Hemostatic Agents Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Medical Hemostatic Agents Sales by Country (2019-2030)
3.4.3 North America Medical Hemostatic Agents Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Medical Hemostatic Agents Market Facts & Figures by Country
3.5.1 Europe Medical Hemostatic Agents Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Medical Hemostatic Agents Sales by Country (2019-2030)
3.5.3 Europe Medical Hemostatic Agents Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Hemostatic Agents Market Facts & Figures by Country
3.6.1 Asia Pacific Medical Hemostatic Agents Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Medical Hemostatic Agents Sales by Country (2019-2030)
3.6.3 Asia Pacific Medical Hemostatic Agents Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Medical Hemostatic Agents Market Facts & Figures by Country
3.7.1 Latin America Medical Hemostatic Agents Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Medical Hemostatic Agents Sales by Country (2019-2030)
3.7.3 Latin America Medical Hemostatic Agents Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medical Hemostatic Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Hemostatic Agents Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Medical Hemostatic Agents Sales by Country (2019-2030)
3.8.3 Middle East and Africa Medical Hemostatic Agents Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Hemostatic Agents Sales by Type (2019-2030)
4.1.1 Global Medical Hemostatic Agents Sales by Type (2019-2024)
4.1.2 Global Medical Hemostatic Agents Sales by Type (2025-2030)
4.1.3 Global Medical Hemostatic Agents Sales Market Share by Type (2019-2030)
4.2 Global Medical Hemostatic Agents Revenue by Type (2019-2030)
4.2.1 Global Medical Hemostatic Agents Revenue by Type (2019-2024)
4.2.2 Global Medical Hemostatic Agents Revenue by Type (2025-2030)
4.2.3 Global Medical Hemostatic Agents Revenue Market Share by Type (2019-2030)
4.3 Global Medical Hemostatic Agents Price by Type (2019-2030)
5 Segment by Application
5.1 Global Medical Hemostatic Agents Sales by Application (2019-2030)
5.1.1 Global Medical Hemostatic Agents Sales by Application (2019-2024)
5.1.2 Global Medical Hemostatic Agents Sales by Application (2025-2030)
5.1.3 Global Medical Hemostatic Agents Sales Market Share by Application (2019-2030)
5.2 Global Medical Hemostatic Agents Revenue by Application (2019-2030)
5.2.1 Global Medical Hemostatic Agents Revenue by Application (2019-2024)
5.2.2 Global Medical Hemostatic Agents Revenue by Application (2025-2030)
5.2.3 Global Medical Hemostatic Agents Revenue Market Share by Application (2019-2030)
5.3 Global Medical Hemostatic Agents Price by Application (2019-2030)
6 Key Companies Profiled
6.1 J&J
6.1.1 J&J Corporation Information
6.1.2 J&J Description and Business Overview
6.1.3 J&J Medical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.1.4 J&J Medical Hemostatic Agents Product Portfolio
6.1.5 J&J Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Corporation Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Medical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Baxter Medical Hemostatic Agents Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 BD
6.3.1 BD Corporation Information
6.3.2 BD Description and Business Overview
6.3.3 BD Medical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BD Medical Hemostatic Agents Product Portfolio
6.3.5 BD Recent Developments/Updates
6.4 Gelita
6.4.1 Gelita Corporation Information
6.4.2 Gelita Description and Business Overview
6.4.3 Gelita Medical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Gelita Medical Hemostatic Agents Product Portfolio
6.4.5 Gelita Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Medical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Medical Hemostatic Agents Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 B Braun
6.6.1 B Braun Corporation Information
6.6.2 B Braun Description and Business Overview
6.6.3 B Braun Medical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.6.4 B Braun Medical Hemostatic Agents Product Portfolio
6.6.5 B Braun Recent Developments/Updates
6.7 CSL Behring
6.6.1 CSL Behring Corporation Information
6.6.2 CSL Behring Description and Business Overview
6.6.3 CSL Behring Medical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CSL Behring Medical Hemostatic Agents Product Portfolio
6.7.5 CSL Behring Recent Developments/Updates
6.8 Ferrosan Medical Devices
6.8.1 Ferrosan Medical Devices Corporation Information
6.8.2 Ferrosan Medical Devices Description and Business Overview
6.8.3 Ferrosan Medical Devices Medical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Ferrosan Medical Devices Medical Hemostatic Agents Product Portfolio
6.8.5 Ferrosan Medical Devices Recent Developments/Updates
6.9 Advance Medical Solution
6.9.1 Advance Medical Solution Corporation Information
6.9.2 Advance Medical Solution Description and Business Overview
6.9.3 Advance Medical Solution Medical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Advance Medical Solution Medical Hemostatic Agents Product Portfolio
6.9.5 Advance Medical Solution Recent Developments/Updates
6.10 Medtronic
6.10.1 Medtronic Corporation Information
6.10.2 Medtronic Description and Business Overview
6.10.3 Medtronic Medical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Medtronic Medical Hemostatic Agents Product Portfolio
6.10.5 Medtronic Recent Developments/Updates
6.11 Z-Medica
6.11.1 Z-Medica Corporation Information
6.11.2 Z-Medica Medical Hemostatic Agents Description and Business Overview
6.11.3 Z-Medica Medical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Z-Medica Medical Hemostatic Agents Product Portfolio
6.11.5 Z-Medica Recent Developments/Updates
6.12 Marine Polymer
6.12.1 Marine Polymer Corporation Information
6.12.2 Marine Polymer Medical Hemostatic Agents Description and Business Overview
6.12.3 Marine Polymer Medical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Marine Polymer Medical Hemostatic Agents Product Portfolio
6.12.5 Marine Polymer Recent Developments/Updates
6.13 Equimedical
6.13.1 Equimedical Corporation Information
6.13.2 Equimedical Medical Hemostatic Agents Description and Business Overview
6.13.3 Equimedical Medical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Equimedical Medical Hemostatic Agents Product Portfolio
6.13.5 Equimedical Recent Developments/Updates
6.14 CryoLife
6.14.1 CryoLife Corporation Information
6.14.2 CryoLife Medical Hemostatic Agents Description and Business Overview
6.14.3 CryoLife Medical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.14.4 CryoLife Medical Hemostatic Agents Product Portfolio
6.14.5 CryoLife Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Hemostatic Agents Industry Chain Analysis
7.2 Medical Hemostatic Agents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Hemostatic Agents Production Mode & Process
7.4 Medical Hemostatic Agents Sales and Marketing
7.4.1 Medical Hemostatic Agents Sales Channels
7.4.2 Medical Hemostatic Agents Distributors
7.5 Medical Hemostatic Agents Customers
8 Medical Hemostatic Agents Market Dynamics
8.1 Medical Hemostatic Agents Industry Trends
8.2 Medical Hemostatic Agents Market Drivers
8.3 Medical Hemostatic Agents Market Challenges
8.4 Medical Hemostatic Agents Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Medical Hemostatic Agents Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Medical Hemostatic Agents Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Medical Hemostatic Agents Market Competitive Situation by Manufacturers in 2023
Table 4. Global Medical Hemostatic Agents Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Medical Hemostatic Agents Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Medical Hemostatic Agents Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Medical Hemostatic Agents Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Medical Hemostatic Agents Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Medical Hemostatic Agents, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Medical Hemostatic Agents, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Medical Hemostatic Agents, Product Type & Application
Table 12. Global Key Manufacturers of Medical Hemostatic Agents, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Medical Hemostatic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Hemostatic Agents as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Medical Hemostatic Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Medical Hemostatic Agents Sales by Region (2019-2024) & (K Units)
Table 18. Global Medical Hemostatic Agents Sales Market Share by Region (2019-2024)
Table 19. Global Medical Hemostatic Agents Sales by Region (2025-2030) & (K Units)
Table 20. Global Medical Hemostatic Agents Sales Market Share by Region (2025-2030)
Table 21. Global Medical Hemostatic Agents Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Medical Hemostatic Agents Revenue Market Share by Region (2019-2024)
Table 23. Global Medical Hemostatic Agents Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Medical Hemostatic Agents Revenue Market Share by Region (2025-2030)
Table 25. North America Medical Hemostatic Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Medical Hemostatic Agents Sales by Country (2019-2024) & (K Units)
Table 27. North America Medical Hemostatic Agents Sales by Country (2025-2030) & (K Units)
Table 28. North America Medical Hemostatic Agents Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Medical Hemostatic Agents Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Medical Hemostatic Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Medical Hemostatic Agents Sales by Country (2019-2024) & (K Units)
Table 32. Europe Medical Hemostatic Agents Sales by Country (2025-2030) & (K Units)
Table 33. Europe Medical Hemostatic Agents Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Medical Hemostatic Agents Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Medical Hemostatic Agents Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Medical Hemostatic Agents Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Medical Hemostatic Agents Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Medical Hemostatic Agents Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Medical Hemostatic Agents Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Medical Hemostatic Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Medical Hemostatic Agents Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Medical Hemostatic Agents Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Medical Hemostatic Agents Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Medical Hemostatic Agents Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Medical Hemostatic Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Medical Hemostatic Agents Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Medical Hemostatic Agents Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Medical Hemostatic Agents Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Medical Hemostatic Agents Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Medical Hemostatic Agents Sales (K Units) by Type (2019-2024)
Table 51. Global Medical Hemostatic Agents Sales (K Units) by Type (2025-2030)
Table 52. Global Medical Hemostatic Agents Sales Market Share by Type (2019-2024)
Table 53. Global Medical Hemostatic Agents Sales Market Share by Type (2025-2030)
Table 54. Global Medical Hemostatic Agents Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Medical Hemostatic Agents Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Medical Hemostatic Agents Revenue Market Share by Type (2019-2024)
Table 57. Global Medical Hemostatic Agents Revenue Market Share by Type (2025-2030)
Table 58. Global Medical Hemostatic Agents Price (US$/Unit) by Type (2019-2024)
Table 59. Global Medical Hemostatic Agents Price (US$/Unit) by Type (2025-2030)
Table 60. Global Medical Hemostatic Agents Sales (K Units) by Application (2019-2024)
Table 61. Global Medical Hemostatic Agents Sales (K Units) by Application (2025-2030)
Table 62. Global Medical Hemostatic Agents Sales Market Share by Application (2019-2024)
Table 63. Global Medical Hemostatic Agents Sales Market Share by Application (2025-2030)
Table 64. Global Medical Hemostatic Agents Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Medical Hemostatic Agents Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Medical Hemostatic Agents Revenue Market Share by Application (2019-2024)
Table 67. Global Medical Hemostatic Agents Revenue Market Share by Application (2025-2030)
Table 68. Global Medical Hemostatic Agents Price (US$/Unit) by Application (2019-2024)
Table 69. Global Medical Hemostatic Agents Price (US$/Unit) by Application (2025-2030)
Table 70. J&J Corporation Information
Table 71. J&J Description and Business Overview
Table 72. J&J Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. J&J Medical Hemostatic Agents Product
Table 74. J&J Recent Developments/Updates
Table 75. Baxter Corporation Information
Table 76. Baxter Description and Business Overview
Table 77. Baxter Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Baxter Medical Hemostatic Agents Product
Table 79. Baxter Recent Developments/Updates
Table 80. BD Corporation Information
Table 81. BD Description and Business Overview
Table 82. BD Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. BD Medical Hemostatic Agents Product
Table 84. BD Recent Developments/Updates
Table 85. Gelita Corporation Information
Table 86. Gelita Description and Business Overview
Table 87. Gelita Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Gelita Medical Hemostatic Agents Product
Table 89. Gelita Recent Developments/Updates
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Pfizer Medical Hemostatic Agents Product
Table 94. Pfizer Recent Developments/Updates
Table 95. B Braun Corporation Information
Table 96. B Braun Description and Business Overview
Table 97. B Braun Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. B Braun Medical Hemostatic Agents Product
Table 99. B Braun Recent Developments/Updates
Table 100. CSL Behring Corporation Information
Table 101. CSL Behring Description and Business Overview
Table 102. CSL Behring Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. CSL Behring Medical Hemostatic Agents Product
Table 104. CSL Behring Recent Developments/Updates
Table 105. Ferrosan Medical Devices Corporation Information
Table 106. Ferrosan Medical Devices Description and Business Overview
Table 107. Ferrosan Medical Devices Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Ferrosan Medical Devices Medical Hemostatic Agents Product
Table 109. Ferrosan Medical Devices Recent Developments/Updates
Table 110. Advance Medical Solution Corporation Information
Table 111. Advance Medical Solution Description and Business Overview
Table 112. Advance Medical Solution Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Advance Medical Solution Medical Hemostatic Agents Product
Table 114. Advance Medical Solution Recent Developments/Updates
Table 115. Medtronic Corporation Information
Table 116. Medtronic Description and Business Overview
Table 117. Medtronic Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Medtronic Medical Hemostatic Agents Product
Table 119. Medtronic Recent Developments/Updates
Table 120. Z-Medica Corporation Information
Table 121. Z-Medica Description and Business Overview
Table 122. Z-Medica Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Z-Medica Medical Hemostatic Agents Product
Table 124. Z-Medica Recent Developments/Updates
Table 125. Marine Polymer Corporation Information
Table 126. Marine Polymer Description and Business Overview
Table 127. Marine Polymer Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Marine Polymer Medical Hemostatic Agents Product
Table 129. Marine Polymer Recent Developments/Updates
Table 130. Equimedical Corporation Information
Table 131. Equimedical Description and Business Overview
Table 132. Equimedical Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Equimedical Medical Hemostatic Agents Product
Table 134. Equimedical Recent Developments/Updates
Table 135. CryoLife Corporation Information
Table 136. CryoLife Description and Business Overview
Table 137. CryoLife Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. CryoLife Medical Hemostatic Agents Product
Table 139. CryoLife Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Medical Hemostatic Agents Distributors List
Table 143. Medical Hemostatic Agents Customers List
Table 144. Medical Hemostatic Agents Market Trends
Table 145. Medical Hemostatic Agents Market Drivers
Table 146. Medical Hemostatic Agents Market Challenges
Table 147. Medical Hemostatic Agents Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Medical Hemostatic Agents
Figure 2. Global Medical Hemostatic Agents Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Medical Hemostatic Agents Market Share by Type in 2023 & 2030
Figure 4. Gelation Hemostats Product Picture
Figure 5. Combination Hemostats Product Picture
Figure 6. Others Product Picture
Figure 7. Global Medical Hemostatic Agents Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Medical Hemostatic Agents Market Share by Application in 2023 & 2030
Figure 9. Hospitals
Figure 10. Surgical Centers
Figure 11. Others
Figure 12. Global Medical Hemostatic Agents Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Medical Hemostatic Agents Market Size (2019-2030) & (US$ Million)
Figure 14. Global Medical Hemostatic Agents Sales (2019-2030) & (K Units)
Figure 15. Global Medical Hemostatic Agents Average Price (US$/Unit) & (2019-2030)
Figure 16. Medical Hemostatic Agents Report Years Considered
Figure 17. Medical Hemostatic Agents Sales Share by Manufacturers in 2023
Figure 18. Global Medical Hemostatic Agents Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Medical Hemostatic Agents Players: Market Share by Revenue in 2023
Figure 20. Medical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Medical Hemostatic Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Medical Hemostatic Agents Sales Market Share by Country (2019-2030)
Figure 23. North America Medical Hemostatic Agents Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Medical Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Medical Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Medical Hemostatic Agents Sales Market Share by Country (2019-2030)
Figure 27. Europe Medical Hemostatic Agents Revenue Market Share by Country (2019-2030)
Figure 28. Germany Medical Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Medical Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Medical Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Medical Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Medical Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Medical Hemostatic Agents Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Medical Hemostatic Agents Revenue Market Share by Region (2019-2030)
Figure 35. China Medical Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Medical Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Medical Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Medical Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Medical Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Medical Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Medical Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Medical Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Medical Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Medical Hemostatic Agents Sales Market Share by Country (2019-2030)
Figure 45. Latin America Medical Hemostatic Agents Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Medical Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Medical Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Medical Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Medical Hemostatic Agents Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Medical Hemostatic Agents Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Medical Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Medical Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Medical Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Medical Hemostatic Agents by Type (2019-2030)
Figure 55. Global Revenue Market Share of Medical Hemostatic Agents by Type (2019-2030)
Figure 56. Global Medical Hemostatic Agents Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Medical Hemostatic Agents by Application (2019-2030)
Figure 58. Global Revenue Market Share of Medical Hemostatic Agents by Application (2019-2030)
Figure 59. Global Medical Hemostatic Agents Price (US$/Unit) by Application (2019-2030)
Figure 60. Medical Hemostatic Agents Value Chain
Figure 61. Medical Hemostatic Agents Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
